Close
ACHEMA MIDDLE EAST 2026

Johnson & Johnson moves up COVID-19 vaccine trial to second half of July

Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of...

Integrity Bio Announces Newly Validated Biotech Manufacturing Line

Integrity Bio has announced the validation of its second fill/finish manufacturing line. This plant expansion more than doubles the company’s manufacturing capacity to meet...

AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccine

AstraZeneca has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker’s latest deal...

UK Pharma Firm Wins US Backing For Antibody-Based COVID-19 Treatment

AstraZeneca has secured support from the US government to advance the development of antibody-based COVID-19 treatments as the British drugmaker ramps up efforts beyond...

UCB Acquires Engage Therapeutics for $125M

UCB announced the acquisition of Engage Therapeutics, Inc. (Summit, N.J. (U.S.)), a clinical-stage pharmaceutical company developing Staccato®Alprazolam for the rapid termination of an active...

Cellbox Solutions Appoints Dr. Herbert Mueller-Hartmann as Head of Research and Development

Cellbox Solutions GmbH announces the appointment of former Head of Biosolutions R&D from Lonza Pharma and Biotech, Dr. Herbert A. Mueller-Hartmann, as the new...

Lonza to Host New Webinar – “The Compendia are ready. Are you? A More Sustainable Future for Endotoxin Testing”

On 16 June, Lonza will host a free 60-minute webinar on the latest regulatory developments surrounding the use of the recombinant Factor C (rFC)...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...